Since the identification of polymorphisms in gene Fas and FasL, a variety of case–control studies have been published to explore the possible association between Fas‐670A/G, Fas‐1377G/A, and FasL‐844T/C and risk of cancer 18, 23, 24, 27; however, the reported results were conflicting. Here, FAS is linked to cancer.